Earnings Preview — 2814 total
CYN reports its Q1 2026 results today against a backdrop of sharply falling short interest and rising price — a combination that concentrates attention on what the numbers actually say about the autonomous vehicle…
Humacyte, Inc. heads into its Q1 2026 earnings release tomorrow with short sellers dug in at levels that leave little margin for disappointment — and a borrow market that has tightened sharply over the past…
Doximity heads into its Q4 FY2026 results today with short sellers meaningfully more aggressive and analysts broadly more cautious than they were just one month ago. Short interest has become the defining positioning…
DRMA heads into its May 14 earnings print with insiders deeply committed — and short sellers cooling off from a frenzied spring. The clearest signal in the data is insider conviction. The CEO, CFO, and a founder each…
Innoviz Technologies reports today with a rare combination of signals: nearly 10% of the float sold short, borrow availability close to fully exhausted, and a stock that has rallied more than 35% in a month — all…
KARO reports its Q4 2026 results today with one of the more striking pre-earnings positioning shifts in recent weeks: short sellers have cut positions by roughly a third over the past month, and the lending market has…
RVPH arrives at today's earnings print after losing more than half its value in a single week — and the short-selling data tells a sharply tightening story behind that move. The borrow market is close to exhausted.…
Motorsport Games Inc. heads into its May 14 results with one of the tightest lending setups in the market — and a major shareholder cashing out amid a sharp price rally. The borrow story is the sharpest signal here.…
PMV Pharmaceuticals heads into its May 15 earnings print having dropped 9% in a single session Wednesday, with short sellers building positions at the fastest monthly rate in recent memory. The most striking feature of…
Lantern Pharma heads into its May 14 earnings report with one of the more charged short-side setups in small-cap biotech right now. Short sellers have built a material position into the print. SI runs at roughly 17.8%…
CCAP reports today with options positioning signalling more caution than the broader lending market warrants. The clearest pre-earnings signal is in options. The put/call ratio jumped to 1.42 on May 13 — roughly 1.7…
IM Cannabis Corp. heads into its May 15 earnings release with one of the most dramatic short-interest collapses of recent weeks, even as the stock itself continues to bleed lower. The standout story is the unwinding of…
Armata Pharmaceuticals reports today against a rough backdrop: the stock has shed 21% over the past month and slipped another 2.6% on the week to $8.82, even as the broader small-cap biotech universe found its footing.…
Aquestive Therapeutics reports Q1 results today with a notable insider selling cluster dominating the pre-earnings backdrop. The insider signal is the sharpest data point heading in. Five executives — including the…
Nexxen International reports today with the Street broadly bullish but targets still well above where the stock trades — a gap that puts real pressure on the print. The valuation setup is unusually striking for a stock…
KULR Technology Group reports today against a backdrop of explosive price momentum and one of the tightest lending markets in the ORTEX universe. The price action alone frames the tension. KULR closed at $4.05 on…
OET heads into its Q1 2026 earnings call with a confirmed beat already on the table. Results released after-market on May 13 showed Q1 adjusted EPS of $2.33, well clear of the $1.74 consensus estimate. Revenue came in…
Lunai Bioworks heads into today's earnings print wrapped in one of the most aggressive short-selling setups in the small-cap biotech universe. Short interest has roughly doubled in the past month. It now runs at nearly…
Short sellers have built one of the most extreme positions in the micro-cap biotech universe heading into GNPX's Q1 results today, and the borrow market confirms the pressure isn't easing. Short interest has more than…
MariMed heads into its May 14 earnings report as one of the OTC cannabis sector's quieter short stories — but the stock's sharp one-month rally makes the print a genuine test of momentum. The lending market tells a…
